Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASP.L Regulatory News (ASP)

  • There is currently no data for ASP

Acquisition

30 Jun 2006 07:03

Ascribe plc30 June 2006 Ascribe plc ("Ascribe" or "the Group") Ascribe acquires Patient Administration System ("PAS") supplier HE Information Systems Limited ("HEIS") for £6.492 million Ascribe (AIM:ASP), the health IT Group, today announces further expansion oftheir offering with the acquisition of HE Information Systems, the supplier ofthe CaMIS clinical and information management system to the UK National HealthService. HEIS provides software to 21 hospitals within the NHS, many of whichalso use Ascribe's Pharmacy or Accident & Emergency systems. The total consideration of £6.492 million is to be satisfied by: • On completion - £2.994m of cash - £0.998m to be satisfied by the issue of 3,326,666 shares in the ordinary capital of Ascribe • Deferred for up to 3 years - £1.25m of cash - £1.25m to be satisfied by the issue of shares in the ordinary capital of Ascribe In the year ended 31 March 2005, HEIS made a profit before tax of £0.52m on aturnover of £2.5m. The value of the net assets being acquired is estimated atapproximately £1.15 million. The Board expects that this acquisition will beearnings enhancing during the first year. This acquisition marks a step change for the Group. The HEIS "PAS" productprovides a strategic offering in the Patient Administration System "PAS" andsecondary care, electronic patient record "EPR" markets. The management willjoin the Ascribe team, allowing the Group to restructure its efforts in linewith the opportunities offered by the delays in the National Programme. Due to personal circumstances, Graham Lewis will resign from the Board witheffect from 31 July 2006. The Board wishes him well for the future. StephenCritchlow will assume the role of CEO and Chairman as the Board focuses onconsolidating the Group and optimising the management team with some keyadditions coming from HEIS. Ascribe recently issued a positive trading update and is pleased to report thattrading continues to be in line with expectations. Ascribe has today applied to AIM for admission of the 3,326,666 initialconsideration shares, which is expected to become effective on Thursday 6 July2006. Commenting, Stephen Critchlow, Executive Chairman of Ascribe, said: "Thisacquisition positions Ascribe firmly as a leading health IT solutions provideracross primary and secondary care. HEIS has an excellent and highlycomplementary product and will also bring a strong, experienced management teamto the Group. We will now be able to drive organic growth from a completeproduct set created from best of breed applications. Any future acquisitionswill only follow once the Group is aligned to this significant opportunity." Contacts: Stephen Critchlow, Executive ChairmanTel: +44(0) 161 280 8080Email: stephen.critchlow@ascribe.com Ginny Pulbrook / Justin Griffiths, Citigate Dewe RogersonTel: +44 (0) 20 7638 9671 About Ascribe plc: Ascribe plc is a leading healthcare company that develops and markets softwaresolutions supporting patient, clinical and business processes to theinternational healthcare market. The Group provides solutions to Emergency andMinor Injuries units, Mental Health and Social Care units, Hospitals requiringpatient administration systems (PAS) and medical equipment management, Hospitaland Retail Pharmacies, and General Practice surgeries. Ascribe plc was floated on AIM in 2004, and currently employs 170 personnelthough its five operating companies in the UK, Hong Kong, Kenya, Australia andNew Zealand. For more information, please visit www.ascribe.com. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
11th May 20072:19 pmRNSHolding(s) in Company
30th Apr 20073:12 pmRNSHolding(s) in Company
27th Apr 20073:09 pmRNSHolding(s) in Company
23rd Mar 20075:05 pmRNSHolding(s) in Company
21st Mar 20077:02 amRNSInterim Results
16th Mar 20075:03 pmRNSHolding(s) in Company
9th Mar 20072:26 pmRNSHolding(s) in Company
9th Mar 20078:43 amRNSHolding(s) in Company
8th Mar 20074:16 pmRNSHolding(s) in Company
6th Mar 20077:02 amRNSNotice of Results
13th Feb 200710:39 amRNSExercise of options
9th Feb 20079:47 amRNSHolding(s) in Company
6th Feb 20071:21 pmRNSDirectorate Change
16th Jan 20071:24 pmRNSHolding(s) in Company
10th Jan 20077:00 amRNSTrading Statement
5th Jan 20075:21 pmRNSIssue of Equity
5th Jan 20074:53 pmRNSHolding(s) in Company
29th Dec 200611:06 amRNSHolding(s) in Company
22nd Dec 200612:47 pmRNSHolding(s) in Company
22nd Dec 200612:44 pmRNSDirector/PDMR Shareholding
20th Dec 200611:36 amRNSIssue of Equity
15th Dec 20062:15 pmRNSTotal Voting Rights
28th Nov 20065:44 pmRNSHolding(s) in Company
23rd Nov 20062:46 pmRNSHolding(s) in Company
21st Nov 200611:37 amRNSHolding(s) in Company
1st Nov 20061:04 pmRNSAGM Statement
30th Oct 20063:30 pmRNSHolding(s) in Company
20th Oct 20065:05 pmRNSHolding(s) in Company
6th Oct 20061:39 pmRNSDirector/PDMR Shareholding
21st Sep 20061:34 pmRNSHolding(s) in Company
19th Sep 20067:03 amRNSAppointment of COO
15th Sep 20065:07 pmRNSDirector/PDMR Shareholding
12th Sep 20067:02 amRNSFinal Results
1st Sep 200611:45 amRNSNotice of Results
21st Aug 20067:00 amRNSChange of Adviser
5th Jul 20065:55 pmRNSHolding(s) in Company
30th Jun 20067:03 amRNSAcquisition
29th Jun 20064:24 pmRNSHolding(s) in Company
16th Jun 20065:22 pmRNSHolding(s) in Company
13th Jun 20062:50 pmRNSDirector/PDMR Shareholding
6th Jun 20064:34 pmRNSDirector/PDMR Shareholding
22nd May 20065:02 pmRNSHolding(s) in Company
11th May 20067:02 amRNSAcquisition
5th May 20067:00 amRNSUpdate on Contract Wins
15th Mar 20067:03 amRNSInterim Results
15th Mar 20067:01 amRNSAcquisition
23rd Feb 20068:12 amRNSHolding(s) in Company
21st Feb 200610:47 amRNSHolding(s) in Company
21st Feb 20069:06 amRNSHolding(s) in Company
7th Feb 20064:28 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.